Insider trade

CME Group (CME): Director reported a transaction in 2,553.78 shares

William R Shepard, Director at CME Group, reported a transaction of 2,553.78 shares.

2,553.78
Shares
Traded
Aug 18, 2026
Filed
Sep 28, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Mar 27, 2026CongressDisclosed purchase of CME — reported range $1,001 - $15,000
  2. Jun 16, 2026CongressDisclosed partial sale of CME — reported range $1,001 - $15,000
  3. Jul 15, 2026Government · Federal Register noticeOrder Under Section 36 of the Securities Exchange Act of 1934 (the “Exchange Act”) and Rule 6h-1(d) Thereunder Granting Conditional Exemptive Relief to the Chicago Mercantile Exchange Inc. From the Opening Price Settlement Requirements of Rule 6h-1(b) Under the Exchange Act for Certain Cash-Settled Security Futures
  4. Jul 22, 2026Company filing · Form 8-K · ResultsReported its results
  5. Aug 3, 2026Government · Federal Register noticeIn the Matter of Nasdaq PHLX LLC; Order Granting Petition for Review and Scheduling Filing of Statements Regarding an Order Approving, on an Accelerated Basis, a Proposed Rule Change, as Modified by Amendment No. 1, To List and Trade Nasdaq Bitcoin Index Options
  6. Aug 6, 2026Government · Federal Register proposed ruleConflicts and Affiliations

What came next

  1. Sep 9, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“As described in the attached press release, CME Group Inc. (“CME Group” or the “Company”) announced new senior leadership appointments in its finance and legal divisions.”
  2. Sep 10, 2026Insider · 1 personInsiders: 2 sales (~$4.1M)
  3. Sep 14, 2026InsiderDirector sold ~$140K of CME shares in the open market
  4. Sep 24, 2026Company filing · Form 8-K · Bylaws or charterChanged its bylaws, charter or fiscal year
  5. Oct 21, 2026Company filing · Form 8-K · ResultsReported its results
  6. Oct 22, 2026InsiderDirector sold ~$121K of CME shares in the open market
  7. Oct 27, 2026InsiderOfficer sold ~$1.49M of CME shares in the open market
  8. Nov 2, 2026Insider · 2 peopleInsiders: 2 sales (~$3.7M)
  9. Nov 9, 2026InsiderDirector sold ~$162K of CME shares in the open market
  10. Nov 18, 2026Insider · 2 peopleInsiders: 3 sales (~$8.6M)
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for CME Group

For CME Group, OQRO holds 22 insider filings (SEC Form 4 or Form 144) and 2 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its CME page.

Other recent filings by William R Shepard, Director

The full history of William R Shepard, Director is on the profile page.

How this filing works

Explore the data

Common questions

Which CME Group (CME) insider traded, and how much?

William R Shepard, Director at CME Group, reported a transaction of 2,553.78 shares. Not an open-market trade.

When did it happen, and when was it made public?

Traded: Aug 18, 2026. Filed: Sep 28, 2026. That is 41 days between the two dates.

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about CME Group recently?

For CME Group, OQRO holds 22 insider filings (SEC Form 4 or Form 144) and 2 fund holdings reports (13F) dated in the last 90 days. They are listed on the CME page.

Does this mean CME stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at CME Group

Everything OQRO holds on this company is on its CME page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data